
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 251
Showing 1-25 of 251 citing articles:
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, et al.
Immunity (2021) Vol. 54, Iss. 12, pp. 2877-2892.e7
Open Access | Times Cited: 428
Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, et al.
Immunity (2021) Vol. 54, Iss. 12, pp. 2877-2892.e7
Open Access | Times Cited: 428
Germinal centre-driven maturation of B cell response to mRNA vaccination
Wooseob Kim, Julian Q. Zhou, Stephen Horváth, et al.
Nature (2022) Vol. 604, Iss. 7904, pp. 141-145
Open Access | Times Cited: 280
Wooseob Kim, Julian Q. Zhou, Stephen Horváth, et al.
Nature (2022) Vol. 604, Iss. 7904, pp. 141-145
Open Access | Times Cited: 280
Correlates of protection against SARS ‐CoV ‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Innate immune mechanisms of mRNA vaccines
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
Science Immunology (2022) Vol. 8, Iss. 79
Open Access | Times Cited: 172
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
Science Immunology (2022) Vol. 8, Iss. 79
Open Access | Times Cited: 172
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 146
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 146
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Count on us: T cells in SARS-CoV-2 infection and vaccination
Katherine Kedzierska, Paul G. Thomas
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100562-100562
Open Access | Times Cited: 116
Katherine Kedzierska, Paul G. Thomas
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100562-100562
Open Access | Times Cited: 116
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 109
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Memory B cells
Takeshi Inoue, Tomohiro Kurosaki
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 5-17
Closed Access | Times Cited: 94
Takeshi Inoue, Tomohiro Kurosaki
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 5-17
Closed Access | Times Cited: 94
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 87
Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 87
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Marios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 879-892.e4
Open Access | Times Cited: 78
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 55
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 55
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 53
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 53